ArticleFrontiers in cardiovascular medicine2025
The association between Chinese visceral adiposity index and hypertension among middle-aged and older population: a cross-sectional study based on CHARLS.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In recent years, obesity has become a serious public health issue. This study aims to investigate the association between the Chinese Visceral Adiposity Index (CVAI) and hypertension among the middle-aged and older population in China. Methods: Data from the China Health and Retirement Longitudinal Study (CHARLS) 2015 wave were used. A 3-knot restricted cubic spline (RCS) was employed to analyze the dose-response relationship between CVAl and hypertension. Logistic regression model was used to explore the association between CVAI and hypertension, adjusting for confounding factors including age, sex, education level, smoking, alcohol consumption, body mass index (BMI), diabetes, hyperlipidemia, and heart disease. Results: A total of 8,787 individuals were included in the study with a hypertension prevalence of 27.89%. A significant association between CVAI and hypertension was observed. Compared to those in the low CVAI category, hypertension was significantly associated with individuals in the high CVAI category in logistic regression (OR adjusted for confounding factors =1.967, 95% CI: 1.781, 2.172). The results showed that the risk of hypertension significantly increased with higher CVAI (trend test Conclusion: CVAI may therefore potentially serve as a useful biomarker for identifying individuals at higher risk, and controlling visceral adiposity accumulation may be a potential target for the prevention and treatment of hypertension.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.